
Pharma News
-
PD-1 agonist development progress inventory, which players on the agonist track?
2023-06-01A New cure for self-avoidance?
-
With annual sales of $1.4 billion, the race is on for the first copy of this innovative drug
2023-06-01When it comes to HIF-PHI drugs, chronic kidney disease anemia will come to mind without thinking.
-
J. Med. Chem. | for new protein degradation molecules of KRAS mutations
2023-06-01Novel protein degrading molecule for KRAS Mutation!
-
Breakthrough and question, Will recombinant Collagen become the next 100 billion track
2023-06-01Despite the skepticism, the effect of recombinant collagen is obvious.
-
Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab
2023-05-29Recently, Biofarma, an Indonesian pharmaceutical company jointly controlled by Ardian and the Scarpa family, announced a final agreement to acquire 100% equity in CDMO company US Pharma Lab.
-
-
MEDEXPO KENYA 2023
2023-05-16The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa's premier medical exhibition, MEDEXPO AFRICA - KENYA 2023.
-
ACS Med. Chem. Lett. | first not two aromatic amine MEK - PROTAC protein JiangXieJi P6b
2023-05-16The first non-diarylamine MEK-PROTAC protein degrader P6b.
-
Huadong Pharmaceutical oral small molecule GLP-1 United States IND approved
2023-05-16China medicine (sz.000963) revealed that its small group glp-1 receptor stimulagent hdm1002 new drug clinical trial (indapplication) was approved by the United States fda for the clinical trial of the I phase of the adult type 2 diabetes.
-
Xuantai medicine mesalazine enteric-coated tablets listed in the United States
2023-05-16Xuantai Pharmaceutical "Mesalazine enteric-coated Tablets (1.2g)" was approved by the US FDA.
-
Astellas and Iveric Bio entered into a definitive agreement to acquire the company
2023-05-16Astellas wants to build the kingdom of ophthalmology.
-
Boanbiodulaglutide injection BA5101 completed phase III clinical trial
2023-05-16All subjects were enrolled in the Phase III clinical trial of Boanbiolatoglytide injection BA5101 in China.
-
Terchang ®, the world's first closed triple inhalation aerosol, was commercially launched in China
2023-05-16Currently the only ultrafine particle triple preparation
-
Wei Mou Biology announced the completion of more than 100 million yuan D2 round of financing
2023-05-08Weimu Biology has completed a D2 round of financing of over 100 million yuan, which will be used for the research and development of innovative ophthalmic drugs.
-
Only 3 drugs have been approved! Frozen life, and $1.16 million worth of drugs
2023-05-08Can new treatments "break the ice"?
-
$860 million market size, PDC drug development and market analysis
2023-05-08Polypeptide-drugconjugate drugs (PDC) are conjugate drug molecules. PDC (Peptide-DrugConjugate) can be used to conjugate peptides with other therapeutic molecules in a covalent manner to produce new compounds.
-
Another big license from Jun Shi. How does Tripley widen the sea road?
2023-05-08The further expansion of the territory.
-
The most expensive acquisition ever! Is Astellas getting its $5.9 billion worth?
2023-05-08Can ACP help Anstey build an ophthalmic kingdom?
-
Two AD new drugs on the market, revenue is negative, Bojian how to recover the loss?
2023-05-04Bojian research and development pipeline sorting
-
23 weight loss drugs approved clinical, Shi Yao, Gan Li, Le Pu...
2023-05-04Analysis report on the pattern of diet drug research in China.
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan